Comments on: Confessions of a Drug Rep http://blog.hcfama.org/2007/11/25/confessions-of-a-drug-rep/ The Ultimate Massachusetts Health Care Insider Information Fri, 10 Feb 2012 15:41:33 +0000 hourly 1 http://wordpress.com/ By: Mandatory Health Insurance is a tax http://blog.hcfama.org/2007/11/25/confessions-of-a-drug-rep/#comment-1229 Tue, 27 Nov 2007 23:58:53 +0000 http://blog.hcfama.org/?p=1300#comment-1229 “influence peddling”

Isn’t that exactly what your organization does?

]]> By: Prescription Project » Blog Archive » All the news that’s fit to print—or e-mail http://blog.hcfama.org/2007/11/25/confessions-of-a-drug-rep/#comment-1228 Mon, 26 Nov 2007 23:01:47 +0000 http://blog.hcfama.org/?p=1300#comment-1228 [...] engagements and ‘ghost-dinners’ under pressure to spend their speaking budgets. More blogs here, here, and [...]

]]> By: Michael D. Miller, MD http://blog.hcfama.org/2007/11/25/confessions-of-a-drug-rep/#comment-1227 Mon, 26 Nov 2007 19:28:30 +0000 http://blog.hcfama.org/?p=1300#comment-1227 One of the subtle and interesting things in this article was the use of Meta-Analyses and selective data presentations (e.g. remission v. response) to make points or derive conclusions about specific medicines or classes of medicines. These types of analyses have been used groups looking to advance or restrict the use or certain types of medicines. The lesson is that every analysis has limitations, and newer studies can modify or change the conclusions from older ones. Physicians cannot have complete knowledge about a particular medicine, or how it compares to other treatment options, or how an individual patient will react/respond to a specific medicine. They need to try and have as great an understanding as they can about the medicines they use most frequently, and to work with both their patients and pharmacists when there are complicated medication situations.

]]>